PCI-32765(Ibrutinib)
2 Inquiries
936563-96-1
99%
2026-07-08
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Inquiry History
-
Description
ProductName PCI-32765(Ibrutinib) Cat No CEI-0270 Description PCI-32765(Ibrutinib) can inhibit bruton tyrosine kinase (Btk) with IC50 of 0.46 nM. CAS No 936563-96-1 Molecular Weight 440.5 Purity >99% Storage 2 years at -20centigrade Powder Targets Bruton tyrosine kinase (Btk) Molecular Formula C25H24N6O2 Chemical Name (R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one Solubility DMSO 88 mg/mL Water In vitro As a selective and irreversible Btk inhibitor, PCI-32765 can inhibit Bruton tyrosine kinase (Btk) with IC50 of 0.46 nM. As Bruton tyrosine kinase (Btk) is specifically required for BCR signaling, PCI-32765 can block BCR signaling pathway by inhibiting Bruton tyrosine kinase (Btk). In CD40 or BCR activated CLL cells, PCI-32765 can inhibit BTK tyrosine phosphorylation and also effectively abrogates downstream survival pathways activated by this kinase including ERK1/2, PI3K, and NF-kappaB. In vitro, PCI-32765 inhibited BCR-activated primary B cell proliferation with IC50 of 8 nM. PCI-32765 blocked BCR signaling in human peripheral B cells at concentrations that did not affect T cell receptor signaling. As B-cell receptor (BCR) signaling is aberrantly activated in chronic lymphocytic leukemia (CLL), PCI-32765 inhibits activation-induced proliferation of CLL cells by inhibiting BTK, and effectively blocks survival signals provided externally to CLL cells from the microenvironment including soluble factors (CD40L, BAFF, IL-6, IL-4, and TNF-alpha), fibronectin engagement, and stromal cell contact. In vivo In MRL-Fas(lpr) lupus model, PCI-32765 reduced the level of circulating autoantibodies and completely suppressed disease. PCI-32765 also inhibited autoantibody production and the development of kidney disease in the MRL-Fas(lpr) lupus model. category Bulk Drug Intermediates(c1112) cas_num 936563-96-1 Basic Info-
Product Name:
Ibrutinib
Other Name:2-Propen-1-one,1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-;1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one;PCI 32765;PCI 32765-00;CRA 032765;Ibrutinib;JNJ 02;Imbruvica;(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one;1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one;1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one;1881245-94-8
CAS No.:936563-96-1
Molecular Formula:C25H24N6O2
InChIKeys:InChIKey=XYFPWWZEPKGCCK-GOSISDBHSA-N
Molecular Weight:440.5
Exact Mass:440.50
EC Number:1308068-626-2
Categories:
Characteristics-
PSA:
99.2
XLogP3:3.6
Density:1.34
Melting Point:149-158ºC
Boiling Point:715.0±60.0°C at 760 mmHg
Flash Point:386.2±32.9 °C
Refractive Index:1.696
Water Solubility:Freely soluble in dimethyl sulfoxide; soluble in methanol
Storage Conditions:Conditions for safe storage, including any incompatibilities: Keep container tightly sealed in cool, well-ventilated area. Keep away from direct sunlight and sources of ignition. Recommended storage temperature: Store at -20 deg C.
Vapor Pressure:3.97X10-15 mm Hg at 25 deg C (est)
PKA:3.74None
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Skin irritation, Category 2
Eye irritation, Category 2
Specific target organ toxicity â single exposure, Category 3
Reproductive toxicity, Category 1B
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Danger
Hazard statement(s) H302 Harmful if swallowed
H315 Causes skin irritation
H319 Causes serious eye irritation
H335 May cause respiratory irritation
H360 May damage fertility or the unborn child
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P271 Use only outdoors or in a well-ventilated area.
P203 Obtain, read and follow all safety instructions before use.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P302+P352 IF ON SKIN: Wash with plenty of water/...
P321 Specific treatment (see ... on this label).
P332+P317 If skin irritation occurs: Get medical help.
P362+P364 Take off contaminated clothing and wash it before reuse.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P319 Get medical help if you feel unwell.
P318 IF exposed or concerned, get medical advice.
Storage P403+P233 Store in a well-ventilated place. Keep container tightly closed.
P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted
United States
Ibrutinib 99% white powder 936563-96-1 wholesale
1 MT Sep 19, 2023
Qatar
Ibrutinib 99% white powder 936563-96-1 Lingding961
100 KG Jul 25, 2023 Post an enquiry for this product